nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.11	0.332	CbGbCtD
Darunavir—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.103	0.308	CbGbCtD
Darunavir—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0471	0.142	CbGbCtD
Darunavir—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0432	0.13	CbGbCtD
Darunavir—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0295	0.0885	CbGbCtD
Darunavir—Amprenavir—ABCB1—peripheral nervous system neoplasm	0.00307	1	CrCbGaD
Darunavir—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000355	CcSEcCtD
Darunavir—Pain—Cisplatin—peripheral nervous system neoplasm	0.000235	0.000355	CcSEcCtD
Darunavir—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000353	CcSEcCtD
Darunavir—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000353	CcSEcCtD
Darunavir—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000232	0.00035	CcSEcCtD
Darunavir—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000232	0.00035	CcSEcCtD
Darunavir—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000232	0.000349	CcSEcCtD
Darunavir—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000349	CcSEcCtD
Darunavir—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000346	CcSEcCtD
Darunavir—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000229	0.000345	CcSEcCtD
Darunavir—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000229	0.000344	CcSEcCtD
Darunavir—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000343	CcSEcCtD
Darunavir—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000227	0.000342	CcSEcCtD
Darunavir—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000226	0.000341	CcSEcCtD
Darunavir—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000341	CcSEcCtD
Darunavir—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.00034	CcSEcCtD
Darunavir—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000339	CcSEcCtD
Darunavir—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000225	0.000339	CcSEcCtD
Darunavir—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000338	CcSEcCtD
Darunavir—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000224	0.000338	CcSEcCtD
Darunavir—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000337	CcSEcCtD
Darunavir—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000223	0.000336	CcSEcCtD
Darunavir—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000334	CcSEcCtD
Darunavir—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000334	CcSEcCtD
Darunavir—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000222	0.000334	CcSEcCtD
Darunavir—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000221	0.000333	CcSEcCtD
Darunavir—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000331	CcSEcCtD
Darunavir—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00022	0.000331	CcSEcCtD
Darunavir—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000219	0.00033	CcSEcCtD
Darunavir—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000329	CcSEcCtD
Darunavir—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000328	CcSEcCtD
Darunavir—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000218	0.000328	CcSEcCtD
Darunavir—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000218	0.000328	CcSEcCtD
Darunavir—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000217	0.000327	CcSEcCtD
Darunavir—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000327	CcSEcCtD
Darunavir—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000325	CcSEcCtD
Darunavir—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000325	CcSEcCtD
Darunavir—Constipation—Etoposide—peripheral nervous system neoplasm	0.000216	0.000325	CcSEcCtD
Darunavir—Pain—Etoposide—peripheral nervous system neoplasm	0.000216	0.000325	CcSEcCtD
Darunavir—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000324	CcSEcCtD
Darunavir—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000324	CcSEcCtD
Darunavir—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000214	0.000322	CcSEcCtD
Darunavir—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000213	0.000321	CcSEcCtD
Darunavir—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.00032	CcSEcCtD
Darunavir—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000318	CcSEcCtD
Darunavir—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000316	CcSEcCtD
Darunavir—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000315	CcSEcCtD
Darunavir—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000315	CcSEcCtD
Darunavir—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000313	CcSEcCtD
Darunavir—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000208	0.000313	CcSEcCtD
Darunavir—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000312	CcSEcCtD
Darunavir—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000207	0.000312	CcSEcCtD
Darunavir—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000206	0.000311	CcSEcCtD
Darunavir—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000206	0.00031	CcSEcCtD
Darunavir—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000205	0.000309	CcSEcCtD
Darunavir—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000309	CcSEcCtD
Darunavir—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000309	CcSEcCtD
Darunavir—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000204	0.000307	CcSEcCtD
Darunavir—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000204	0.000307	CcSEcCtD
Darunavir—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000306	CcSEcCtD
Darunavir—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000203	0.000305	CcSEcCtD
Darunavir—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000305	CcSEcCtD
Darunavir—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000202	0.000305	CcSEcCtD
Darunavir—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000304	CcSEcCtD
Darunavir—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000303	CcSEcCtD
Darunavir—Urticaria—Etoposide—peripheral nervous system neoplasm	0.0002	0.000302	CcSEcCtD
Darunavir—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000301	CcSEcCtD
Darunavir—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000301	CcSEcCtD
Darunavir—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000301	CcSEcCtD
Darunavir—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000199	0.0003	CcSEcCtD
Darunavir—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000199	0.0003	CcSEcCtD
Darunavir—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000199	0.0003	CcSEcCtD
Darunavir—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000199	0.0003	CcSEcCtD
Darunavir—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000298	CcSEcCtD
Darunavir—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000198	0.000298	CcSEcCtD
Darunavir—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000198	0.000297	CcSEcCtD
Darunavir—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000296	CcSEcCtD
Darunavir—Rash—Vincristine—peripheral nervous system neoplasm	0.000196	0.000296	CcSEcCtD
Darunavir—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000196	0.000295	CcSEcCtD
Darunavir—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000295	CcSEcCtD
Darunavir—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000294	CcSEcCtD
Darunavir—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000294	CcSEcCtD
Darunavir—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000294	CcSEcCtD
Darunavir—Headache—Vincristine—peripheral nervous system neoplasm	0.000195	0.000294	CcSEcCtD
Darunavir—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000292	CcSEcCtD
Darunavir—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000291	CcSEcCtD
Darunavir—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.000289	CcSEcCtD
Darunavir—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000289	CcSEcCtD
Darunavir—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000188	0.000284	CcSEcCtD
Darunavir—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000283	CcSEcCtD
Darunavir—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000282	CcSEcCtD
Darunavir—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00028	CcSEcCtD
Darunavir—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000186	0.00028	CcSEcCtD
Darunavir—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000279	CcSEcCtD
Darunavir—Nausea—Vincristine—peripheral nervous system neoplasm	0.000185	0.000278	CcSEcCtD
Darunavir—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000278	CcSEcCtD
Darunavir—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000278	CcSEcCtD
Darunavir—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000277	CcSEcCtD
Darunavir—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000277	CcSEcCtD
Darunavir—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000276	CcSEcCtD
Darunavir—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000274	CcSEcCtD
Darunavir—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000273	CcSEcCtD
Darunavir—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000181	0.000273	CcSEcCtD
Darunavir—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000272	CcSEcCtD
Darunavir—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000272	CcSEcCtD
Darunavir—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000272	CcSEcCtD
Darunavir—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000271	CcSEcCtD
Darunavir—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000179	0.00027	CcSEcCtD
Darunavir—Chills—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000269	CcSEcCtD
Darunavir—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000178	0.000269	CcSEcCtD
Darunavir—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000267	CcSEcCtD
Darunavir—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000265	CcSEcCtD
Darunavir—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000175	0.000264	CcSEcCtD
Darunavir—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000263	CcSEcCtD
Darunavir—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000262	CcSEcCtD
Darunavir—Rash—Cisplatin—peripheral nervous system neoplasm	0.000174	0.000261	CcSEcCtD
Darunavir—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000173	0.000261	CcSEcCtD
Darunavir—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000261	CcSEcCtD
Darunavir—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000261	CcSEcCtD
Darunavir—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000173	0.00026	CcSEcCtD
Darunavir—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000259	CcSEcCtD
Darunavir—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000257	CcSEcCtD
Darunavir—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000257	CcSEcCtD
Darunavir—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000257	CcSEcCtD
Darunavir—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000255	CcSEcCtD
Darunavir—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000252	CcSEcCtD
Darunavir—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000167	0.000251	CcSEcCtD
Darunavir—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000251	CcSEcCtD
Darunavir—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.00025	CcSEcCtD
Darunavir—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.00025	CcSEcCtD
Darunavir—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000249	CcSEcCtD
Darunavir—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000164	0.000246	CcSEcCtD
Darunavir—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000245	CcSEcCtD
Darunavir—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000243	CcSEcCtD
Darunavir—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000242	CcSEcCtD
Darunavir—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00016	0.000241	CcSEcCtD
Darunavir—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000241	CcSEcCtD
Darunavir—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000241	CcSEcCtD
Darunavir—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000241	CcSEcCtD
Darunavir—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000159	0.00024	CcSEcCtD
Darunavir—Rash—Etoposide—peripheral nervous system neoplasm	0.000159	0.000239	CcSEcCtD
Darunavir—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000159	0.000239	CcSEcCtD
Darunavir—Headache—Etoposide—peripheral nervous system neoplasm	0.000158	0.000238	CcSEcCtD
Darunavir—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000238	CcSEcCtD
Darunavir—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000236	CcSEcCtD
Darunavir—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000235	CcSEcCtD
Darunavir—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000234	CcSEcCtD
Darunavir—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000234	CcSEcCtD
Darunavir—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000234	CcSEcCtD
Darunavir—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000232	CcSEcCtD
Darunavir—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000231	CcSEcCtD
Darunavir—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000229	CcSEcCtD
Darunavir—Cough—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000228	CcSEcCtD
Darunavir—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000226	CcSEcCtD
Darunavir—Nausea—Etoposide—peripheral nervous system neoplasm	0.00015	0.000226	CcSEcCtD
Darunavir—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000225	CcSEcCtD
Darunavir—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000224	CcSEcCtD
Darunavir—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000223	CcSEcCtD
Darunavir—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000222	CcSEcCtD
Darunavir—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000222	CcSEcCtD
Darunavir—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000222	CcSEcCtD
Darunavir—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000222	CcSEcCtD
Darunavir—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000221	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000221	CcSEcCtD
Darunavir—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000219	CcSEcCtD
Darunavir—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000218	CcSEcCtD
Darunavir—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000217	CcSEcCtD
Darunavir—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000217	CcSEcCtD
Darunavir—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000216	CcSEcCtD
Darunavir—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000216	CcSEcCtD
Darunavir—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000215	CcSEcCtD
Darunavir—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000213	CcSEcCtD
Darunavir—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000212	CcSEcCtD
Darunavir—Cough—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000211	CcSEcCtD
Darunavir—Shock—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000209	CcSEcCtD
Darunavir—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000209	CcSEcCtD
Darunavir—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000209	CcSEcCtD
Darunavir—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000208	CcSEcCtD
Darunavir—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000208	CcSEcCtD
Darunavir—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000208	CcSEcCtD
Darunavir—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000207	CcSEcCtD
Darunavir—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000206	CcSEcCtD
Darunavir—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000205	CcSEcCtD
Darunavir—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000205	CcSEcCtD
Darunavir—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000205	CcSEcCtD
Darunavir—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000205	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000204	CcSEcCtD
Darunavir—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000203	CcSEcCtD
Darunavir—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000203	CcSEcCtD
Darunavir—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000201	CcSEcCtD
Darunavir—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000199	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000194	CcSEcCtD
Darunavir—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000194	CcSEcCtD
Darunavir—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000193	CcSEcCtD
Darunavir—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000193	CcSEcCtD
Darunavir—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000193	CcSEcCtD
Darunavir—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000192	CcSEcCtD
Darunavir—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000191	CcSEcCtD
Darunavir—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000191	CcSEcCtD
Darunavir—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00019	CcSEcCtD
Darunavir—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000126	0.00019	CcSEcCtD
Darunavir—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000189	CcSEcCtD
Darunavir—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000188	CcSEcCtD
Darunavir—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000187	CcSEcCtD
Darunavir—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000185	CcSEcCtD
Darunavir—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000184	CcSEcCtD
Darunavir—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000184	CcSEcCtD
Darunavir—Pain—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000182	CcSEcCtD
Darunavir—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000182	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000179	CcSEcCtD
Darunavir—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000178	CcSEcCtD
Darunavir—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000177	CcSEcCtD
Darunavir—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000176	CcSEcCtD
Darunavir—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000175	CcSEcCtD
Darunavir—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000175	CcSEcCtD
Darunavir—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000174	CcSEcCtD
Darunavir—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000173	CcSEcCtD
Darunavir—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000171	CcSEcCtD
Darunavir—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.00017	CcSEcCtD
Darunavir—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.00017	CcSEcCtD
Darunavir—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000169	CcSEcCtD
Darunavir—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000168	CcSEcCtD
Darunavir—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000168	CcSEcCtD
Darunavir—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000168	CcSEcCtD
Darunavir—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000168	CcSEcCtD
Darunavir—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000162	CcSEcCtD
Darunavir—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000161	CcSEcCtD
Darunavir—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000157	CcSEcCtD
Darunavir—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000156	CcSEcCtD
Darunavir—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000156	CcSEcCtD
Darunavir—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000156	CcSEcCtD
Darunavir—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000153	CcSEcCtD
Darunavir—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000151	CcSEcCtD
Darunavir—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	9.67e-05	0.000146	CcSEcCtD
Darunavir—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	9.64e-05	0.000145	CcSEcCtD
Darunavir—Asthenia—Doxorubicin—peripheral nervous system neoplasm	9.39e-05	0.000141	CcSEcCtD
Darunavir—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.35e-05	0.000141	CcSEcCtD
Darunavir—Pruritus—Doxorubicin—peripheral nervous system neoplasm	9.26e-05	0.000139	CcSEcCtD
Darunavir—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.99e-05	0.000135	CcSEcCtD
Darunavir—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.95e-05	0.000135	CcSEcCtD
Darunavir—Rash—Epirubicin—peripheral nervous system neoplasm	8.91e-05	0.000134	CcSEcCtD
Darunavir—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.91e-05	0.000134	CcSEcCtD
Darunavir—Headache—Epirubicin—peripheral nervous system neoplasm	8.86e-05	0.000133	CcSEcCtD
Darunavir—Dizziness—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.00013	CcSEcCtD
Darunavir—Nausea—Epirubicin—peripheral nervous system neoplasm	8.4e-05	0.000126	CcSEcCtD
Darunavir—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8.32e-05	0.000125	CcSEcCtD
Darunavir—Rash—Doxorubicin—peripheral nervous system neoplasm	8.25e-05	0.000124	CcSEcCtD
Darunavir—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.000124	CcSEcCtD
Darunavir—Headache—Doxorubicin—peripheral nervous system neoplasm	8.2e-05	0.000123	CcSEcCtD
Darunavir—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.77e-05	0.000117	CcSEcCtD
